Latest News on Gen-Probe Inc. (GPRO) Stock

• Cancer Diagnostic Testing World Markets [May 22 2013 06:18 AM]
Cancer Diagnostic Testing World Markets   MarketWatch (press release) - 21 hours ago ... Inc. 2206.35 Exiqon 2216.36 Fujirebio Diagnostics, Inc. 2216.37 Gene Logic, Inc. 2226.38 Gen-Probe, Inc. 2226.39 Genomic Health, Inc. 2226.40 Geron Corporation 2236.41 Hologic, Inc. (formerly Cytyc Corporation) 2246.42 Immunicon Corporation (now ... Molecular Diagnostics in Cancer Testing - Internation... Read more about this Gen-Probe Inc. (GPRO) news

• Trading is cautious [May 21 2013 12:02 PM]
Trading is cautious   Proactive Investors USA & Canada - May 21, 2013 Medistem, Inc. (PINKS: MEDS) appointed Herm Rosenman to its Board of Directors and Chairman of the Audit Committee. Rosenman was Senior Vice President and Chief Financial Officer of Gen-Probe, Inc., from 2001, through its IPO in 2002, until its ... Read more about this Gen-Probe Inc. (GPRO) news

• Global Molecular Diagnostics Market 2012-2016 [May 20 2013 11:03 AM]
Global Molecular Diagnostics Market 2012-2016   Sacramento Bee - May 20, 2013 ... Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd. Read more about this Gen-Probe Inc. (GPRO) news

• Registration Extended Until May 22 for Association of Bioscience Financial ... [May 16 2013 05:11 AM]
Registration Extended Until May 22 for Association of Bioscience Financial ...   Wall Street Journal (press release) - May 16, 2013 ... Center of Excellence Hologic | Gen-Probe -- Will Waddell, Sr. Vice President, Chief Financial Officer, OncoMed Pharmaceuticals, Inc. -- Robert Williamson, Founder, LaSalle Venture Advisers, Former Director, Pharmasset -- Troy Wilson, President and ... Read more about this Gen-Probe Inc. (GPRO) news

Looking for Market Opportunties?